Selected research
Industry Research
Maternal Mental Health Industry Research Report 2026
Market perspective
The global Maternal Mental Health market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
North America: the Maternal Mental Health market is projected to increase from US$ million in 2026 to US$ million by 2032, reflecting a CAGR of % over 2026–2032. Europe: the Maternal Mental Health market is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032. Asia Pacific: the Maternal Mental Health market is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032. Leading global service providers of Maternal Mental Health include Lipocine, Pfizer, Viatris, Bold Health, Glaxo Smith Kline Inc., Alembic Pharmaceuticals Limited, Mallinckrodt, Sage Therapeutics, Inc. and Bausch Health Companies Inc. and among others; in 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
Read the full market overview
This report quantifies the global Maternal Mental Health market in terms of revenue (US$ million) and, where applicable, service volume (k units), using 2024 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of service Types and end-use Applications, harmonizes provider attribution, and delivers comparable time series by company, Type, Application, and region or country, including indicative price bands (US$/k units) and concentration ratios (CR5/CR10). Outputs are intended to support service design, budgeting, capacity planning, and benchmarking for providers, platforms, channel partners, and investors; the report also reviews technology shifts and notable service innovations relevant to Maternal Mental Health.
Key Companies & Market Share Insights
This section profiles leading service providers with 2021–2025 results and a 2026–2032 outlook—covering revenue, market share, price bands, service portfolio and client mix, regional and channel mix, and key developments (M&A, network expansion, certifications). It also provides global revenue, average price, and—where applicable—volume metrics by provider, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Maternal Mental Health Market by Company
Lipocine
Pfizer
Viatris
Bold Health
Glaxo Smith Kline Inc.
Alembic Pharmaceuticals Limited
Mallinckrodt
Sage Therapeutics, Inc.
Bausch Health Companies Inc.
Magellan Health
Maternal Mental Health Segment by Type
Antidepressants
Interpersonal Psychotherapy
Cognitive Behavioural Therapy
Others
Maternal Mental Health Segment by Application
Clinics
Hospitals
Others
Maternal Mental Health Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Spain
Russia
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Colombia
Middle East & Africa
Saudi Arabia
Israel
United Arab Emirates
Turkey
Iran
Egypt
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Maternal Mental Health market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Maternal Mental Health and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Maternal Mental Health.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 6: Detailed analysis of Maternal Mental Health companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, South America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 13: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Antidepressants
- Interpersonal Psychotherapy
- Cognitive Behavioural Therapy
- Others
Applications
- Clinics
- Hospitals
- Others
Companies covered
- Lipocine
- Pfizer
- Viatris
- Bold Health
- Glaxo Smith Kline Inc.
- Alembic Pharmaceuticals Limited
- Mallinckrodt
- Sage Therapeutics, Inc.
- Bausch Health Companies Inc.
- Magellan Health
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Maternal Mental Health by Type
- 2.2.1 Market Value Comparison by Type (2021 VS 2025 VS 2032)
- 2.2.2 Antidepressants
- 2.2.3 Interpersonal Psychotherapy
- 2.2.4 Cognitive Behavioural Therapy
- 2.2.5 Others
- 2.3 Maternal Mental Health by Application
- 2.3.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.3.2 Clinics
- 2.3.3 Hospitals
- 2.3.4 Others
- 2.4 Assumptions and Limitations
3 Maternal Mental Health Breakdown Data by Type
- 3.1 Global Maternal Mental Health Historic Market Size by Type (2021-2026)
- 3.2 Global Maternal Mental Health Forecasted Market Size by Type (2027-2032)
4 Maternal Mental Health Breakdown Data by Application
- 4.1 Global Maternal Mental Health Historic Market Size by Application (2021-2026)
- 4.2 Global Maternal Mental Health Forecasted Market Size by Application (2027-2032)
5 Global Growth Trends
- 5.1 Global Maternal Mental Health Market Perspective (2021-2032)
- 5.2 Global Maternal Mental Health Growth Trends by Region
- 5.2.1 Global Maternal Mental Health Market Size by Region: 2021 VS 2025 VS 2032
- 5.2.2 Maternal Mental Health Historic Market Size by Region (2021-2026)
- 5.2.3 Maternal Mental Health Forecasted Market Size by Region (2027-2032)
- 5.3 Maternal Mental Health Market Dynamics
- 5.3.1 Maternal Mental Health Industry Trends
- 5.3.2 Maternal Mental Health Market Drivers
- 5.3.3 Maternal Mental Health Market Challenges
- 5.3.4 Maternal Mental Health Market Restraints
6 Market Competitive Landscape by Players
- 6.1 Global Top Maternal Mental Health Players by Revenue
- 6.1.1 Global Top Maternal Mental Health Players by Revenue (2021-2026)
- 6.1.2 Global Maternal Mental Health Revenue Market Share by Players (2021-2026)
- 6.2 Global Maternal Mental Health Industry Players Ranking, 2023 VS 2024 VS 2025
- 6.3 Global Key Players of Maternal Mental Health Head Office and Area Served
- 6.4 Global Maternal Mental Health Players, Product Type & Application
- 6.5 Global Maternal Mental Health Manufacturers Established Date
- 6.6 Global Maternal Mental Health Market CR5 and HHI
- 6.7 Global Players Mergers & Acquisition
7 North America
- 7.1 North America Maternal Mental Health Market Size (2021-2032)
- 7.2 North America Maternal Mental Health Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 7.3 North America Maternal Mental Health Market Size by Country (2021-2026)
- 7.4 North America Maternal Mental Health Market Size by Country (2027-2032)
- 7.5 United States
- 7.5 United States
- 7.6 Canada
- 7.7 Mexico
8 Europe
- 8.1 Europe Maternal Mental Health Market Size (2021-2032)
- 8.2 Europe Maternal Mental Health Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.3 Europe Maternal Mental Health Market Size by Country (2021-2026)
- 8.4 Europe Maternal Mental Health Market Size by Country (2027-2032)
- 8.5 Germany
- 8.6 France
- 8.7 U.K.
- 8.8 Italy
- 8.9 Spain
- 8.10 Russia
- 8.11 Netherlands
- 8.12 Nordic Countries
9 Asia-Pacific
- 9.1 Asia-Pacific Maternal Mental Health Market Size (2021-2032)
- 9.2 Asia-Pacific Maternal Mental Health Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 9.3 Asia-Pacific Maternal Mental Health Market Size by Country (2021-2026)
- 9.4 Asia-Pacific Maternal Mental Health Market Size by Country (2027-2032)
- 9.5 China
- 9.6 Japan
- 9.7 South Korea
- 9.8 India
- 9.9 Australia
- 9.10 China Taiwan
- 9.11 Southeast Asia
10 South America
- 10.1 South America Maternal Mental Health Market Size (2021-2032)
- 10.2 South America Maternal Mental Health Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 10.3 South America Maternal Mental Health Market Size by Country (2021-2026)
- 10.4 South America Maternal Mental Health Market Size by Country (2027-2032)
- 10.5 Brazil
- 10.6 Argentina
- 10.7 Chile
- 10.8 Colombia
- 10.9 Peru
11 Middle East & Africa
- 11.1 Middle East & Africa Maternal Mental Health Market Size (2021-2032)
- 11.2 Middle East & Africa Maternal Mental Health Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 11.3 Middle East & Africa Maternal Mental Health Market Size by Country (2021-2026)
- 11.4 Middle East & Africa Maternal Mental Health Market Size by Country (2027-2032)
- 11.5 Saudi Arabia
- 11.6 Israel
- 11.7 United Arab Emirates
- 11.8 Turkey
- 11.9 Iran
- 11.10 Egypt
12 Players Profiled
- 12.1 Lipocine
- 12.1.1 Lipocine Company Information
- 12.1.2 Lipocine Business Overview
- 12.1.3 Lipocine Revenue in Maternal Mental Health Business (2021-2026)
- 12.1.4 Lipocine Maternal Mental Health Product Portfolio
- 12.1.5 Lipocine Recent Developments
- 12.2 Pfizer
- 12.2.1 Pfizer Company Information
- 12.2.2 Pfizer Business Overview
- 12.2.3 Pfizer Revenue in Maternal Mental Health Business (2021-2026)
- 12.2.4 Pfizer Maternal Mental Health Product Portfolio
- 12.2.5 Pfizer Recent Developments
- 12.3 Viatris
- 12.3.1 Viatris Company Information
- 12.3.2 Viatris Business Overview
- 12.3.3 Viatris Revenue in Maternal Mental Health Business (2021-2026)
- 12.3.4 Viatris Maternal Mental Health Product Portfolio
- 12.3.5 Viatris Recent Developments
- 12.4 Bold Health
- 12.4.1 Bold Health Company Information
- 12.4.2 Bold Health Business Overview
- 12.4.3 Bold Health Revenue in Maternal Mental Health Business (2021-2026)
- 12.4.4 Bold Health Maternal Mental Health Product Portfolio
- 12.4.5 Bold Health Recent Developments
- 12.5 Glaxo Smith Kline Inc.
- 12.5.1 Glaxo Smith Kline Inc. Company Information
- 12.5.2 Glaxo Smith Kline Inc. Business Overview
- 12.5.3 Glaxo Smith Kline Inc. Revenue in Maternal Mental Health Business (2021-2026)
- 12.5.4 Glaxo Smith Kline Inc. Maternal Mental Health Product Portfolio
- 12.5.5 Glaxo Smith Kline Inc. Recent Developments
- 12.6 Alembic Pharmaceuticals Limited
- 12.6.1 Alembic Pharmaceuticals Limited Company Information
- 12.6.2 Alembic Pharmaceuticals Limited Business Overview
- 12.6.3 Alembic Pharmaceuticals Limited Revenue in Maternal Mental Health Business (2021-2026)
- 12.6.4 Alembic Pharmaceuticals Limited Maternal Mental Health Product Portfolio
- 12.6.5 Alembic Pharmaceuticals Limited Recent Developments
- 12.7 Mallinckrodt
- 12.7.1 Mallinckrodt Company Information
- 12.7.2 Mallinckrodt Business Overview
- 12.7.3 Mallinckrodt Revenue in Maternal Mental Health Business (2021-2026)
- 12.7.4 Mallinckrodt Maternal Mental Health Product Portfolio
- 12.7.5 Mallinckrodt Recent Developments
- 12.8 Sage Therapeutics, Inc.
- 12.8.1 Sage Therapeutics, Inc. Company Information
- 12.8.2 Sage Therapeutics, Inc. Business Overview
- 12.8.3 Sage Therapeutics, Inc. Revenue in Maternal Mental Health Business (2021-2026)
- 12.8.4 Sage Therapeutics, Inc. Maternal Mental Health Product Portfolio
- 12.8.5 Sage Therapeutics, Inc. Recent Developments
- 12.9 Bausch Health Companies Inc.
- 12.9.1 Bausch Health Companies Inc. Company Information
- 12.9.2 Bausch Health Companies Inc. Business Overview
- 12.9.3 Bausch Health Companies Inc. Revenue in Maternal Mental Health Business (2021-2026)
- 12.9.4 Bausch Health Companies Inc. Maternal Mental Health Product Portfolio
- 12.9.5 Bausch Health Companies Inc. Recent Developments
- 12.10 Magellan Health
- 12.10.1 Magellan Health Company Information
- 12.10.2 Magellan Health Business Overview
- 12.10.3 Magellan Health Revenue in Maternal Mental Health Business (2021-2026)
- 12.10.4 Magellan Health Maternal Mental Health Product Portfolio
- 12.10.5 Magellan Health Recent Developments
13 Report Conclusion
14 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst